Serplus Technology LLC

AutoGrid Systems is a leading provider of advanced energy management solutions based in Redwood City, CA. Their innovative software platform enables the efficient management and optimization of distributed energy resources, including demand response, virtual power plants, microgrids, and energy storage. With a strong focus on grid reliability and sustainability, AutoGrid empowers utilities, grid operators, and energy service providers to effectively integrate renewable energy sources and enhance grid flexibility. As a subsidiary of Schneider Electric, AutoGrid is committed to ethical business practices and has joined Schneider Electric's Trustline program. This program ensures that suppliers and partners adhere to high ethical standards, including human rights, labor laws, and environmental protection. With a global presence, AutoGrid is dedicated to driving the transition to a clean and resilient energy future.Generated from the website

Dorian Therapeutics, Inc. is a biotechnology company located in San Carlos, California, focused on advancing scientific research and innovation. The company is committed to addressing significant challenges in the field through its dedicated team of scientists and advisors. With a strong emphasis on collaboration, Dorian Therapeutics engages with various communities to foster knowledge sharing and development. Their mission is to contribute to the scientific landscape by exploring novel therapeutic approaches and solutions. Generated from the website

Meissa Vaccines Inc is a biotechnology company based in Redwood City, CA, dedicated to developing live attenuated vaccines for respiratory viruses such as RSV and COVID-19. Their innovative technologies, including the proprietary AttenuBlock platform, aim to deliver effective vaccines globally, preventing infection and generating a strong immune response. With a mission to safeguard people worldwide from life-threatening respiratory viruses, Meissa Vaccines focuses on developing safe and highly attenuated vaccine candidates that induce a better immune response than natural infection. Their RSV and COVID-19 vaccine candidates are designed to provide a durable immune response by stimulating mucosal IgA and serum neutralizing antibodies.Generated from the website